XENT News and Press, Intersect ENT Inc. From 01/25/22

Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL ® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including a...

Intersect ENT (NASDAQ:XENT) received a "second request" from the Federal Trade Commission on Sept. 22 regarding its planned sale to Medtronic (NYSE:MDT) according to 8-K filing yesterday. Intersect (XENT) believes its sale remains on track to close toward the end of Medtronic's fiscal ye...

Intersect ENT (NASDAQ:XENT): Q3 Non-GAAP EPS of -$0.48 misses by $0.06; GAAP EPS of -$0.95 misses by $0.57. Revenue of $24.4M (+7.4% Y/Y) misses by $5.83M. Press Release For further details see: Intersect ENT EPS misses by $0.06, misses on revenue

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 million for the third qu...

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to...

Qualcomm and SSW Partners outbid Magna to buy Veoneer. Veoneer to pay a termination fee of $110 million to Magna. Meredith Corporation acquired by IAC/InterActiveCorp and Gray Television. For further details see: Merger Arbitrage Mondays - Qualcomm And SSW Partners Win T...

Merck acquires Acceleron for $180 per share in cash. Amicus Therapeutics to launch a genetic medicine company, Caritas Therapeutics through a business combination agreement with ARYA Sciences Acquisition Corp IV. Five9 and Zoom Video Communications mutually terminate their merger ...

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV) concerning potential violations of the federal securities laws and/or breaches of fiduciary...

Sanofi makes a second purchase just six weeks after its $2 billion deal for Translate Bio. Potential deal in the works, Columbia Property Trust comes to fruition. Macquarie Infrastructure Partners completes the acquisition of Cincinnati Bell. For further details see: Mer...

NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV) concerning potential violations of the federal securities laws and/or breaches of fiduciary d...